Lineage Cell Therapeutics (LCTX) Price to Book Value: 4.173

Lineage Cell Therapeutics, Inc. (LCTX)

1.005 -0.02 (-2.43%) USD | NYAM | Oct 30, 16:00

1.005 0.00 (0.00%) After-Hours: 18:02

Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 1998. Start Trial.

Date	Value
October 29, 2026	4.276
October 28, 2026	4.318
October 27, 2026	4.276
October 26, 2026	4.139
October 23, 2026	4.152
October 22, 2026	4.090
October 21, 2026	3.950
October 20, 2026	4.038
October 19, 2026	3.956
October 16, 2026	4.062
October 15, 2026	4.112
October 14, 2026	3.809
October 13, 2026	3.771
October 12, 2026	3.961
October 09, 2026	4.127
October 08, 2026	4.276
October 07, 2026	3.934
October 06, 2026	3.894
October 05, 2026	3.850
October 02, 2026	3.862
October 01, 2026	3.754
September 30, 2026	3.968
September 29, 2026	3.934
September 28, 2026	4.031
September 25, 2026	4.276

Date	Value
September 24, 2026	3.935
September 23, 2026	3.972
September 22, 2026	4.318
September 21, 2026	4.193
September 18, 2026	4.276
September 17, 2026	4.276
September 16, 2026	4.442
September 15, 2026	4.401
September 14, 2026	4.442
September 11, 2026	4.193
September 10, 2026	4.235
September 09, 2026	4.276
September 08, 2026	4.526
September 04, 2026	4.484
September 03, 2026	4.567
September 02, 2026	4.608
September 01, 2026	4.484
August 31, 2026	4.567
August 28, 2026	4.608
August 27, 2026	4.816
August 26, 2026	4.65
August 25, 2026	4.692
August 24, 2026	4.526
August 21, 2026	4.484
August 20, 2026	4.484

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks